Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 2 | $481,009 |
| Sells | 34 | $12,499,884 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 25 Sep 2024 20:54 | LGND | LIGAND PHARMACEUTICALS INC | REARDON ANDREW | CLO & Secretary | 23 Sep 2024 | Sale | 2,000 | 99.6005 | 199,201 | D |
| 24 Sep 2024 19:41 | LGND | LIGAND PHARMACEUTICALS INC | ESPINOZA OCTAVIO | Chief Financial Officer | 20 Sep 2024 | Sale | 800 | 103.95 | 83,160 | D |
| 24 Sep 2024 19:41 | LGND | LIGAND PHARMACEUTICALS INC | ESPINOZA OCTAVIO | Chief Financial Officer | 20 Sep 2024 | Sale | 275 | 103.8625 | 28,562 | D |
| 24 Sep 2024 19:41 | LGND | LIGAND PHARMACEUTICALS INC | ESPINOZA OCTAVIO | Chief Financial Officer | 20 Sep 2024 | Sale | 200 | 103.98 | 20,796 | D |
| 24 Sep 2024 19:41 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 23 Sep 2024 | Sale | 201 | 102.0541 | 20,513 | D |
| 24 Sep 2024 19:41 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 23 Sep 2024 | Sale | 2,481 | 100.0517 | 248,228 | D |
| 24 Sep 2024 19:41 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 23 Sep 2024 | Sale | 7,090 | 101.605 | 720,379 | D |
| 24 Sep 2024 19:41 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 20 Sep 2024 | Sale | 6,275 | 104.1017 | 653,238 | D |
| 30 Aug 2024 20:56 | LGND | LIGAND PHARMACEUTICALS INC | REARDON ANDREW | CLO & Secretary | 28 Aug 2024 | Sale | 1,500 | 106.3937 | 159,591 | D |
| 26 Aug 2024 20:15 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 26 Aug 2024 | Sale | 5,212 | 106.3214 | 554,147 | D |
| 26 Aug 2024 20:15 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 26 Aug 2024 | Sale | 6,177 | 105.016 | 648,684 | D |
| 26 Aug 2024 20:15 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 23 Aug 2024 | Sale | 4,275 | 105.1319 | 449,439 | D |
| 26 Aug 2024 20:15 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 23 Aug 2024 | Sale | 2,037 | 104.0945 | 212,040 | D |
| 26 Aug 2024 20:15 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 22 Aug 2024 | Sale | 1,157 | 105.54 | 122,110 | D |
| 13 Aug 2024 17:21 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & COO | 09 Aug 2024 | Sale | 18,245 | 98.5 | 1,797,132 | D |
| 09 Aug 2024 17:52 | LGND | LIGAND PHARMACEUTICALS INC | DAVIS TODD C | Chief Executive Officer | 08 Aug 2024 | Purchase | 2,500 | 97.3922 | 243,480 | D |
| 17 May 2024 20:00 | LGND | LIGAND PHARMACEUTICALS INC | GRAY NANCY RYAN | Director | 09 May 2024 | Sale | 934 | 83.2049 | 77,713 | D |
| 17 May 2024 19:59 | LGND | LIGAND PHARMACEUTICALS INC | ESPINOZA OCTAVIO | Chief Financial Officer | 17 May 2024 | Sale | 134 | 86.6497 | 11,611 | D |
| 17 May 2024 19:59 | LGND | LIGAND PHARMACEUTICALS INC | ESPINOZA OCTAVIO | Chief Financial Officer | 17 May 2024 | Sale | 5,022 | 86.6652 | 435,233 | D |
| 17 May 2024 19:59 | LGND | LIGAND PHARMACEUTICALS INC | ESPINOZA OCTAVIO | Chief Financial Officer | 16 May 2024 | Sale | 2,264 | 86.0034 | 194,712 | D |
| 17 May 2024 19:59 | LGND | LIGAND PHARMACEUTICALS INC | ESPINOZA OCTAVIO | Chief Financial Officer | 15 May 2024 | Sale | 5,873 | 86.012 | 505,148 | D |
| 15 May 2024 19:34 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & Chief Operating | 14 May 2024 | Sale | 520 | 85.6841 | 44,556 | D |
| 15 May 2024 19:34 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & Chief Operating | 14 May 2024 | Sale | 13,638 | 85.0826 | 1,160,356 | D |
| 15 May 2024 19:34 | LGND | LIGAND PHARMACEUTICALS INC | KORENBERG MATTHEW E | President & Chief Operating | 13 May 2024 | Sale | 3,440 | 84.5431 | 290,828 | D |
| 13 May 2024 17:32 | LGND | LIGAND PHARMACEUTICALS INC | REARDON ANDREW | Chief Legal Officer & | 09 May 2024 | Sale | 10,000 | 83.0449 | 830,449 | D |
| 07 Mar 2024 13:27 | LGND | LIGAND PHARMACEUTICALS INC | SABBA STEPHEN L | Director | 05 Mar 2024 | Sale | 1,893 | 74.3 | 140,650 | D |
| 29 Feb 2024 18:50 | LGND | LIGAND PHARMACEUTICALS INC | ESPINOZA OCTAVIO | Chief Financial Officer | 28 Feb 2024 | Sale | 140 | 88.46 | 12,384 | D |
| 25 Sep 2023 16:44 | LGND | LIGAND PHARMACEUTICALS INC | DAVIS TODD C | CHIEF EXECUTIVE OFFICER | 22 Sep 2023 | Purchase | 4,000 | 59.3822 | 237,529 | D |
| 18 May 2023 17:18 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | 16 May 2023 | Sale | 4,444 | 77.2009 | 343,081 | D |
| 12 May 2023 15:43 | LGND | LIGAND PHARMACEUTICALS INC | SABBA STEPHEN L | Director | 10 May 2023 | Sale | 6,408 | 77.1262 | 494,225 | D |
| 10 May 2023 19:15 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | 08 May 2023 | Sale | 589 | 77.0974 | 45,410 | D |
| 10 May 2023 19:15 | LGND | LIGAND PHARMACEUTICALS INC | KOZARICH JOHN W | Director | 08 May 2023 | Sale | 5,819 | 76.511 | 445,218 | D |
| 28 Mar 2023 17:00 | LGND | LIGAND PHARMACEUTICALS INC | REARDON ANDREW | See Remarks | 24 Mar 2023 | Sale | 300 | 69.9243 | 20,977 | D |
| 20 Dec 2022 18:36 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Director | 16 Dec 2022 | Sale | 10,000 | 61.8657 | 618,657 | D |
| 21 Nov 2022 19:04 | LGND | LIGAND PHARMACEUTICALS INC | HIGGINS JOHN L | Chief Executive Officer | 17 Nov 2022 | Sale | 10,000 | 78.3173 | 783,173 | D |
| 10 Nov 2022 16:30 | LGND | LIGAND PHARMACEUTICALS INC | ESPINOZA OCTAVIO | Chief Financial Officer | 09 Nov 2022 | Sale | 1,696 | 75.6383 | 128,283 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)